Cancer Stem Cell News
Cell Therapy News
Dermal Cell News
Endothelial Cell News
ESC & iPSC News
Extracellular Matrix News
Hematopoiesis News
Hepatic Cell News
Human Immunology News
Immune Regulation News
Intestinal Cell News
Mammary Cell News
Mesenchymal Cell News
Muscle Cell News
Neural Cell News
Organoid News
Pancreatic Cell News
Prostate Cell News
Pulmonary Cell NewsScientists investigated the effects of the PI3K inhibitor LY‑294002 and AKT inhibitor MK2206 on the chemosensitivity of oxaliplatin‑resistant liver cancer cells and the molecular mechanism involved.
[Molecular Medicine Reports]
7753456 {7753456:SSITR55E} apa 50 1 162251 https://www.stemcellsciencenews.com/wp-content/plugins/zotpress/
%7B%22status%22%3A%22success%22%2C%22updateneeded%22%3Afalse%2C%22instance%22%3A%22zotpress-31b0741ce7506715c8eede768d91e7a8%22%2C%22meta%22%3A%7B%22request_last%22%3A0%2C%22request_next%22%3A0%2C%22used_cache%22%3Atrue%7D%2C%22data%22%3A%5B%7B%22key%22%3A%22SSITR55E%22%2C%22library%22%3A%7B%22id%22%3A7753456%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Xu%20et%20al.%22%2C%22parsedDate%22%3A%222021-07-01%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3EXu%2C%20R.%2C%20Zhang%2C%20Y.%2C%20Li%2C%20A.%2C%20Ma%2C%20Y.%2C%20Cai%2C%20W.%2C%20Song%2C%20L.%2C%20Xie%2C%20Y.%2C%20Zhou%2C%20S.%2C%20Cao%2C%20W.%2C%20%26amp%3B%20Tang%2C%20X.%20%282021%29.%20LY%26%23x2011%3B294002%20enhances%20the%20chemosensitivity%20of%20liver%20cancer%20to%20oxaliplatin%20by%20blocking%20the%20PI3K%5C%2FAKT%5C%2FHIF%26%23x2011%3B1%26%23x3B1%3B%20pathway.%20%3Ci%3EMolecular%20Medicine%20Reports%3C%5C%2Fi%3E%2C%20%3Ci%3E24%3C%5C%2Fi%3E%281%29%2C%201%26%23x2013%3B11.%20%3Ca%20href%3D%27https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.3892%5C%2Fmmr.2021.12147%27%3Ehttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.3892%5C%2Fmmr.2021.12147%3C%5C%2Fa%3E%20%3Ca%20title%3D%27Cite%20in%20RIS%20Format%27%20class%3D%27zp-CiteRIS%27%20href%3D%27https%3A%5C%2F%5C%2Fwww.stemcellsciencenews.com%5C%2Fwp-content%5C%2Fplugins%5C%2Fzotpress%5C%2Flib%5C%2Frequest%5C%2Frequest.cite.php%3Fapi_user_id%3D7753456%26amp%3Bitem_key%3DSSITR55E%27%3ECite%3C%5C%2Fa%3E%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22LY%5Cu2011294002%20enhances%20the%20chemosensitivity%20of%20liver%20cancer%20to%20oxaliplatin%20by%20blocking%20the%20PI3K%5C%2FAKT%5C%2FHIF%5Cu20111%5Cu03b1%20pathway%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ruyue%22%2C%22lastName%22%3A%22Xu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yinci%22%2C%22lastName%22%3A%22Zhang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Amin%22%2C%22lastName%22%3A%22Li%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yongfang%22%2C%22lastName%22%3A%22Ma%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Wenpeng%22%2C%22lastName%22%3A%22Cai%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Li%22%2C%22lastName%22%3A%22Song%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yinghai%22%2C%22lastName%22%3A%22Xie%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Shuping%22%2C%22lastName%22%3A%22Zhou%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Weiya%22%2C%22lastName%22%3A%22Cao%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Xiaolong%22%2C%22lastName%22%3A%22Tang%22%7D%5D%2C%22abstractNote%22%3A%22Liver%20cancer%20remains%20one%20of%20the%20leading%20causes%20of%20cancer%20deaths%20worldwide.%20The%20therapeutic%20effect%20of%20oxaliplatin%20on%20liver%20cancer%20is%20often%20limited%20by%20acquired%20resistance%20of%20the%20cancer%20cells.%20Abnormal%20activation%20of%20the%20PI3K%5C%2FAKT%20pathway%20plays%20an%20important%20role%20in%20the%20acquired%20resistance%20of%20oxaliplatin.%20The%20present%20study%20investigated%20the%20effects%20of%20the%20PI3K%20inhibitor%20LY%5Cu2011294002%20and%20AKT%20inhibitor%20MK2206%20on%20the%20chemosensitivity%20of%20oxaliplatin%5Cu2011resistant%20liver%20cancer%20cells%20and%20the%20molecular%20mechanism%20involved.%20An%20oxaliplatin%5Cu2011resistant%20liver%20cancer%20cell%20line%20HepG2%3Csup%3ER%3C%5C%2Fsup%3E%20was%20developed.%20MTT%20assay%2C%20clone%20formation%20experiments%2C%20flow%20cytometry%20and%20Annexin%5Cu00a0V%5Cu2011FITC%5C%2FPI%20staining%20were%20used%20to%20determine%20the%20proliferation%2C%20cycle%20and%20apoptosis%20of%20HepG2%3Csup%3ER%3C%5C%2Fsup%3E%20cells%20when%20oxaliplatin%20was%20combined%20with%20LY%5Cu2011294002%20or%20MK2206%20treatment.%20The%20effects%20of%20LY%5Cu2011294002%20and%20MK%5Cu20112206%20on%20the%20abnormal%20activation%20of%20PI3K%5C%2FAKT%20pathway%20and%20hypoxia%20inducible%20factor%20%28HIF%29%5Cu20111%5Cu03b1%20protein%20level%20in%20HepG2%3Csup%3ER%3C%5C%2Fsup%3E%20cells%20were%20detected%20using%20western%20blotting.%20The%20results%20indicated%20that%20the%20PI3K%5C%2FAKT%20pathway%20is%20stably%20activated%20in%20HepG2%3Csup%3ER%3C%5C%2Fsup%3E%20cells.%20Compared%20with%20the%20AKT%20inhibitor%20MK2206%2C%20the%20PI3K%20inhibitor%20LY%5Cu2011294002%20more%20effectively%20downregulated%20the%20phosphorylation%20levels%20of%20p85%2C%20p110%5Cu03b1%2C%20p110%5Cu03b2%2C%20p110%5Cu03b3%20and%20AKT%20in%20the%20PI3K%5C%2FAKT%20pathway%20in%20HepG2%3Csup%3ER%3C%5C%2Fsup%3E%20cells%2C%20and%20more%20effectively%20inhibited%20the%20proliferation%20of%20the%20cells.%20LY%5Cu2011294002%20enhanced%20the%20chemotherapy%20sensitivity%20of%20HepG2R%20cells%20to%20oxaliplatin%20by%20inducing%20G%3Csub%3E0%3C%5C%2Fsub%3E%5C%2FG%3Csub%3E1%3C%5C%2Fsub%3E%5Cu00a0phase%20arrest%20and%20increasing%20the%20proportion%20of%20apoptotic%20cells.%20In%20addition%2C%20LY%5Cu2011294002%20reduced%20the%20level%20of%20HIF%5Cu20111%5Cu03b1%2C%20which%20is%20highly%20expressed%20in%20HepG2%3Csup%3ER%3C%5C%2Fsup%3E%20cells.%20It%20was%20concluded%20that%20LY%5Cu2011294002%20enhanced%20the%20chemosensitivity%20of%20liver%20cancer%20cells%20to%20oxaliplatin%20by%20inhibiting%20the%20PI3K%5C%2FAKT%20signaling%20pathway%2C%20which%20may%20be%20related%20to%20the%20inhibition%20of%20HIF%5Cu20111%5Cu03b1%20expression.%20These%20findings%20may%20have%20clinical%20significance%20for%20the%20treatment%20of%20oxaliplatin%5Cu2011resistant%20liver%20cancer.%22%2C%22date%22%3A%222021-07-01%22%2C%22language%22%3A%22%22%2C%22DOI%22%3A%2210.3892%5C%2Fmmr.2021.12147%22%2C%22ISSN%22%3A%221791-2997%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fwww.spandidos-publications.com%5C%2F10.3892%5C%2Fmmr.2021.12147%22%2C%22deleted%22%3A1%2C%22collections%22%3A%5B%22NTMX856R%22%5D%2C%22dateModified%22%3A%222021-05-14T17%3A03%3A51Z%22%7D%7D%5D%7D
Xu, R., Zhang, Y., Li, A., Ma, Y., Cai, W., Song, L., Xie, Y., Zhou, S., Cao, W., & Tang, X. (2021). LY‑294002 enhances the chemosensitivity of liver cancer to oxaliplatin by blocking the PI3K/AKT/HIF‑1α pathway. Molecular Medicine Reports, 24(1), 1–11. https://doi.org/10.3892/mmr.2021.12147 Cite
